
zzso commonly occurs among cancer patients receiving zzso In these patients, zzso agents zzso are effective in managing anemia but there is an increased risk for zzso zzso In more recent zzso clinical trials, there have been differing results regarding the impact of zzso on overall survival and zzso The balance between studies that show higher zzso mortality and those that don't show zzso mortality is examined in this zzso This review discusses where we stand today on anemia management in cancer zzso zzso results from a recent independent patient data zzso for zzso deaths and overall survival in patients receiving chemotherapy (the only zzso population for which zzso treatment is currently zzso showed no statistically significant difference between the zzso and control groups zzso deaths hazard ratio zzso zzso zzso confidence zzso zzso zzso overall survival HR, zzso zzso zzso zzso compared with zzso zzso factors that could influence study results are discussed in this zzso There are no convincing data to support zzso tumor stimulation in zzso zzso decrease zzso zzso needs and sustain targeted zzso levels, and this zzso response does not significantly impact overall survival or mortality when zzso are used within guidelines and zzso However, based on the currently available data and zzso the use of zzso has to be carefully balanced against any possible risk for higher zzso 

